PM

Pinnenti Meenakshi

Director Additional Director DIN 02531593
DIN 02531593 First appointment Oct 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2008
Shareholding value •••• Premium profile

About Pinnenti Meenakshi

Data last updated:

Pinnenti Meenakshi was an Additional Director at Rakshit Pharmaceuticals Limited (2008–2009) and Director at Vimal Drugs Private Limited (2009–2012). The companies operate in Pharma.

DIN 02531593
Primary Designation Additional Director
Industry Pharma
First Appointment 03 Oct 2008

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rakshit Pharmaceuticals Limited U24239TG2005PLC048151
Additional Director03 Oct 20082005₹238 Cr (FY 2024)Active
Vimal Drugs Private Limited U24100TG2009PTC063551
Director05 May 20092009₹76.99 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rakshit Pharmaceuticals Limited
Vimal Drugs Private Limited
Premium access

Shareholding and investment profile for Pinnenti Meenakshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pinnenti Meenakshi

Pinnenti Meenakshi was first appointed on 03 Oct 2008 as Additional Director at Rakshit Pharmaceuticals Limited. The most recent appointment on record is 05 May 2009 at Vimal Drugs Private Limited.

Pinnenti Meenakshi held 2 earlier board appointments: Rakshit Pharmaceuticals Limited (Additional Director, 03 Oct 2008 to 29 Apr 2009); Vimal Drugs Private Limited (Director, 05 May 2009 to 28 May 2012).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available